Revaccination in Age-Risk Groups with Sputnik V Is Immunologically Effective and Depends on the Initial Neutralizing SARS-CoV-2 IgG Antibodies Level

MLA

Mikhail A. Godkov, et al. “Revaccination in Age-Risk Groups with Sputnik V Is Immunologically Effective and Depends on the Initial Neutralizing SARS-CoV-2 IgG Antibodies Level.” Vaccines, vol. 11, no. 1, Dec. 2022, p. 90. EBSCOhost, https://doi.org/10.3390/vaccines11010090.

APA

Mikhail A. Godkov, Darya A. Ogarkova, Vladimir A. Gushchin, Denis A. Kleymenov, Elena P. Mazunina, Evgeniia N. Bykonia, Andrei A. Pochtovyi, Valeriy V. Shustov, Dmitry V. Shcheblyakov, Andrey G. Komarov, Alexander N. Tsibin, Vladimir I. Zlobin, Denis Y. Logunov, & Alexander L. Gintsburg. (2022). Revaccination in Age-Risk Groups with Sputnik V Is Immunologically Effective and Depends on the Initial Neutralizing SARS-CoV-2 IgG Antibodies Level. Vaccines, 11(1), 90. https://doi.org/10.3390/vaccines11010090

Chicago

Mikhail A. Godkov, Darya A. Ogarkova, Vladimir A. Gushchin, Denis A. Kleymenov, Elena P. Mazunina, Evgeniia N. Bykonia, Andrei A. Pochtovyi, et al. 2022. “Revaccination in Age-Risk Groups with Sputnik V Is Immunologically Effective and Depends on the Initial Neutralizing SARS-CoV-2 IgG Antibodies Level.” Vaccines 11 (1): 90. doi:10.3390/vaccines11010090.